Clinical Trials on Primary Central Nervous Lymphoma in France

Total 10505 results

Eli Lilly and Company
Loxo Oncology, Inc.

Active, not recruiting

Study of Oral LOXO-338 in Patients With Advanced Blood Cancers

Lymphoma, Non-Hodgkin | B-cell Lymphoma | Multiple Myeloma | Lymphoma, Mantle-Cell | Waldenstrom Macroglobulinemia | Leukemia, Lymphocytic, Chronic, B-Cell | Lymphoma, B-cell Marginal Zone

United States, France, Poland, Italy
Central Hospital, Nancy, France

Unknown

Evaluation of the Effect of Hydration About Orthostatic Hypotension in the Elderly. Difference With Venous Compression (CHHO)

Orthostatic Hypotension

France
Swiss Group for Clinical Cancer Research

Completed

Everolimus in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

Lymphoma

France, Switzerland, Italy
BeiGene

Completed

Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms

Cutaneous T-cell Lymphoma | Anaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Adult Nasal Type Extranodal NK/T-cell Lymphoma | Anaplastic Large Cell Lymphoma, ALK-Positive | Extranodal NK/T-cell Lymphoma, Nasal Type | Peripheral T Cell Lymphoma | Extranodal NK/T-cell Lymphoma | Peripheral... and other conditions

China, Taiwan, Germany, France, Canada, Italy
Institut Paoli-Calmettes

Unknown

Cladribine Dose Escalation in Conditioning Regimen Prior to Allo-HSCT for Refractory Acute Leukemia and Myelodysplastic Syndromes (CEREAL)

Leukemia, Myeloid, Acute | Leukemia, Lymphoblastic, Acute

France
Centre Leon Berard

Completed

An Individualized Physical Activity Program in Patients Over 65 Years With Hematologic Malignancies (OCAPI)

Quality of Life | Lymphoma, Non-Hodgkin | Leukemia, Myeloid, Acute | Fatigue | Exercise | Aged | Aged, 80 and Over

France
SecuraBio

Completed

A Phase 3 Study of Duvelisib Versus Ofatumumab in Patients With Relapsed or Refractory CLL/SLL (DUO)

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma

Belgium, France, Italy, Spain, United States, Austria, New Zealand, Hungary, Germany, United Kingdom, Australia
Centre Hospitalier Universitaire de Saint Etienne

Completed

Interest of Relaxation From Patients With Pain Due to Migraine (MIGREL)

Migraine

France
University Hospital, Limoges

Suspended

Uterine Allotransplantations Using Uterine Grafts From Brain-dead Female Donors (ATU)

Infertility

France
Centre d'Investigation Clinique et Technologique...

Completed

Importance of Sleep Deprivation in Differential Diagnosis of Primary Hypersomnia (Actisom dépistage) (Actisom)

Hypersomnia

France
University of Washington
CLL Global Research Foundation

Active, not recruiting

Immune Response to SARS-CoV-2 (COVID-19) Vaccines in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma

United States
Centre Hospitalier Universitaire de Nice

Unknown

Cerebral Metabolism in Patients With Refractory Chronic Cluster Headache Treated by Occipital Nerve Stimulation (MET-ONS)

Refractory Chronic Cluster Headache

France
Assistance Publique - Hôpitaux de Paris

Completed

Effective Volemia in Older Adults With Orthostatic Hypotension (EVO)

Orthostatic Hypotension

France
Remedee SA

Completed

Migraine STImulation Crisis of Migraine (MISTIC)

Migraine Without Aura

France
Centre Leon Berard

Recruiting

Impact of a Multidisciplinary End-of-treatment Day Hospital on the Quality of Life of Adolescents and Young Adults With Cancer (HOPAYA)

Lymphoma | Solid Tumor

France
University Hospital, Clermont-Ferrand

Not yet recruiting

Migraine and Neuropathic Pain in Osteoarthritis (MEDUSA)

Osteoarthritis | Migraine | Neuropathic Pain

France
miRagen Therapeutics, Inc.

Terminated

SOLAR: Efficacy and Safety of Cobomarsen (MRG-106) vs. Active Comparator in Subjects With Mycosis Fungoides (SOLAR)

Cutaneous T-Cell Lymphoma/Mycosis Fungoides

United States, France, Spain, Canada, United Kingdom, Australia, Italy, Belgium
University Hospital, Montpellier

Active, not recruiting

Sensitivity to Acute Cerebral Ischemia in Migrainers (SAMCO-MIG)

Ischemic Stroke | Migraine | Migraine With Aura

France
University Hospital, Toulouse

Completed

Effect on Patient Quality of Life of Taking Into Account the Spiritual Dimension in Nurse's Care for Haematologic Cancers. (SPIEVIE)

Lymphoma | Acute Leukemia

France
Centre Hospitalier Universitaire de Pointe-a-Pitre

Recruiting

Epidemiology and Pathophysiology of Parkinsonism in the Caribbeans (CAP)

Atypical Parkinsonism

Martinique, French Guiana
University Hospital, Bordeaux

Recruiting

Quality of Life of Caregivers and Patients Suffering From Multiple System Atrophy (QUA2-AMS)

Multiple System Atrophy

France
Centre Hospitalier Universitaire de Besancon

Unknown

Access to Maternity and Risk Factors in a Non-consultant Population (PROXIMA)

Post Partum Depression

France
Institut Cancerologie de l'Ouest

Completed

Feasibility of MRI Workflow Alone in External Radiotherapy for the Treatment of Brain and Prostate Tumors (PRIS)

Prostate Cancer | Brain Cancer

France
University Hospital, Grenoble

Completed

Evaluation of the Prophylactic Efficacy of tDCS in Chronic Migraine (Medis)

Chronic Migraine as Defined by Criteria of International Headache Society (IHS)

France
Children's Oncology Group
National Cancer Institute (NCI)

Recruiting

Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia

Recurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Recurrent B Lymphoblastic Lymphoma | Refractory B Lymphoblastic Lymphoma

United States, Puerto Rico
University Hospital, Rouen

Terminated

NEUROTOX: Two Dosages of Type A Botulinic Toxin in Neurogenic Overactive Bladder

Overactive Bladder

France
Affimed GmbH
Artiva Biotherapeutics, Inc.

Recruiting

Phase 2 Study of AFM13 in Combination With AB-101 in Subjects With R/R HL and CD30+ PTCL (LuminICE-203)

Peripheral T Cell Lymphoma | Relapsed or Refractory Hodgkin Lymphoma

United States
Cell Medica Ltd

Terminated

Cellular Immunotherapy Treatment Antigen-Directed for EBV Lymphoma (CITADEL)

Lymphoma, Extranodal NK-T-Cell | EBV

Korea, Republic of, United States, France, United Kingdom
University Hospital, Lille

Recruiting

GENetic Fronto Temporal Dementia Initiative in Lille (GENFI-LILLE)

Frontotemporal Dementia

France
University Hospital, Caen

Unknown

Bilateral vs. Unilateral Stimulation in Neurological Bladder Disroders (UROSTIM)

Neurogenic Urinary Bladder, Spastic

France
Centre Hospitalier Universitaire de Besancon
Assistance Publique - Hôpitaux de Paris; Centre Hospitalier Universitaire Dijon

Unknown

tDCS Effect on Cognitive Functions From Patients With Alzheimer's Disease or Progressive Primary Aphasia (ALSTICO)

Alzheimer's Disease | Progressive Primary Aphasia | Early or Mild State

France
Nantes University Hospital

Completed

Efficacy and Tolerability of Memantine in Frontotemporal Dementia (FTD) Patients

Dementia

France
National Cancer Institute (NCI)

Recruiting

A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia

Down Syndrome | B Acute Lymphoblastic Leukemia | B Lymphoblastic Lymphoma

United States, Canada, Puerto Rico, Australia, New Zealand
Gérard Amarenco

Completed

Time to be Ready to Void: a New Tool to Assess the Time Needed to Perform Micturition in Multiple Sclerosis

Multiple Sclerosis | Gait Disorders, Neurologic | Urinary Incontinence, Urge

France
Centre d'Investigation Clinique et Technologique...

Completed

Toxin Retrospective Study (NDOTOX)

Neurogenic Bladder

France
Pierre and Marie Curie University

Completed

AQUA: Anticholinergic Side Effects QUestionnAire (AQUA)

Overactive Bladder

France
SecuraBio

Completed

A Phase 3 Extension Study of Duvelisib and Ofatumumab in Participants With CLL/SLL Previously Enrolled in Study IPI-145-07

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma

Belgium, France, Italy, Spain, United States, Austria, New Zealand, Hungary, United Kingdom, Australia, Germany
Janssen Research & Development, LLC

Recruiting

A Study of JNJ-80948543, a T-cell Redirecting CD79b x CD20 x CD3 Trispecific Antibody, in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)

Lymphoma, Non-Hodgkin | Leukemia, Lymphocytic, Chronic, B-Cell

United States, China, France, Denmark, Israel, Poland, Australia
H.A.C. PHARMA

Recruiting

Efficacy and Tolerance of Flucortac in Patients With Orthostatic Neurogenic Hypotension

Neurogenic Orthostatic Hypotension

France
Assistance Publique - Hôpitaux de Paris

Recruiting

The Patient Cohort of the National Center for Precision Medicine in Leukemia (eTHEMA)

Acute Myeloid Leukemia | Acute Lymphoblastic Leukemia | High-risk Myelodysplastic Syndrome | Myeloproliferative Neoplasm, Unclassifiable | Secondary Myelofibrosis in Myeloproliferative Disease

France
Groupe Hospitalier Pitie-Salpetriere

Completed

a Vigibase Pharmacovigilance Study of ENzalutamide Drug-induced neurotoxicitY (VENDY)

Epilepsy | Prostate Cancer | Neuropathy | Encephalopathy

France
Genmab
AbbVie

Recruiting

Study of the Adverse Events and Change in Disease State of Pediatric Participants (and Young Adults Between the Ages of 18-25) With Relapsed/Refractory Aggressive Mature B-cell Neoplasms Receiving Subcutaneous (SC) Injections of Epcoritamab

Non-hodgkin Lymphoma

United States, Australia, France, Israel, Korea, Republic of, Spain, Taiwan, Japan, Italy, Belgium, Germany, Canada, Turkey, Czechia
GB005, Inc., a wholly owned subsidiary of Gossamer...

Terminated

GB5121 in Adult Patients With Relapsed/Refractory CNS Lymphoma (STAR CNS)

CNS Lymphoma

United States, Canada, Israel, Australia, New Zealand, France
Institut de Recherches Internationales Servier
ADIR, a Servier Group company

Completed

Study of a New Intravenous Drug, Called S65487, in Patients With Acute Myeloid Leukemia, Non Hodgkin Lymphoma, Multiple Myeloma or Chronic Lymphocytic Leukemia

Relapsed or Refractory Multiple Myeloma | Relapsed or Refractory Acute Myeloid Leukemia | Relapsed or Refractory Non-Hodgkin Lymphoma | Relapsed or Refractory Chronic Lymphocytic Leukemia

United Kingdom, Spain, France, Australia
Celgene

Terminated

A Safety and Efficacy Study of CC-90011 in Participants With Relapsed and/or Refractory Solid Tumors and Non-Hodgkin's Lymphomas

Neoplasms | Lymphoma, Non-Hodgkin

France, Italy, Japan, Spain, United Kingdom
National Cancer Institute (NCI)

Completed

Temsirolimus, Dexamethasone, Mitoxantrone Hydrochloride, Vincristine Sulfate, and Pegaspargase in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma

Recurrent Childhood Acute Lymphoblastic Leukemia | Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Recurrent Childhood Lymphoblastic Lymphoma | Childhood T Acute Lymphoblastic Leukemia | Childhood B Acute Lymphoblastic Leukemia

United States, Canada
Pierre and Marie Curie University

Completed

French Version of the Short Form of Neurogenic Bladder Symptom Score

Neurogenic Bladder

France
University Hospital, Bordeaux

Completed

Impact of Local Biopsy to the Endometrium Prior to Controlled Ovarian Stimulation on Clinical Pregnancy (NIDABRECHE)

Primary or Secondary Infertility

France
University Hospital, Toulouse
The MSA Coalition

Recruiting

Therapeutic Education for Multiple System Atrophy (MSA) Patients and Their Caregivers (ETP@MS)

Multiple System Atrophy

France
Neurim Pharmaceuticals Ltd.

Completed

Sleep Inducing And Maintaining Efficacy Of Circadin In Elderly Insomniacs (Neu I)

Primary Insomnia

France

Clinical Trials on Primary Central Nervous Lymphoma in France

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Rwanda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations